View our On Demand Webinar "Viral shedding and infectivity testing in clinical trials of oncolytic virotherapies", presented by Kristen Mickey, MS, Research Scientist, R&D.
Developments in molecular and genomics technologies are dramatically improving the opportunities for development of more effective cancer therapeutics. We offer a broad range of molecular and genomic services to support translational and precision medicine approaches to clinical development. With a wide range of viral and bacterial targets, our clients have access to a broad menu of real-time PCR and quantitative assays for pathogen detection and monitoring, biodistribution and shedding.
Our PCR technology expertise includes: qPCR, RT-PCR, TEM-PCR, ddPCR; and extends across a variety of applications and therapeutic areas.